PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges

Article

Applied Clinical Trials

PAREXEL International Corporation, a provider of global biopharmaceutical services, announced that it has developed new solutions that take a patient-centric approach to addressing drug development. These solutions were built on the Perceptive Cloud platform in hopes to leverage mobile and wearable technology.

Read the full release here.  

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.